Statistical issues in the design and planning of proteomic profiling experiments

Area of Science:

• Proteomics
• Biostatistics
• Biomarker Discovery

Background:

• Clinical proteomics experiments involve analyzing numerous proteins simultaneously.
• Effective statistical design is crucial for robust and reproducible proteomic investigations.
• Standard experimental design principles (randomization, replication, blocking) are fundamental but require adaptation for proteomic scale.

Purpose of the Study:

• To outline the importance of statistical design in clinical proteomics.
• To address the complexities of determining replicate numbers in high-throughput proteomic studies.
• To provide a framework for achieving powerful experiments in biomarker discovery and validation.

Main Methods:

• Applying core principles of experimental design, including randomization, replication, and blocking.
• Utilizing experimental information and making simplifying assumptions to estimate required sample sizes.
• Adapting statistical methodologies for the unique challenges of proteomic data analysis.

Main Results:

• Statistical design is achievable even with the large number of proteins in discovery experiments.
• The number of replicates can be determined effectively by leveraging experimental specifics.
• This approach supports the development of powerful studies for biomarker discovery and initial validation.

Conclusions:

• Sound statistical design is essential for successful clinical proteomics.
• Methodologies exist to determine appropriate replication for powerful proteomic experiments.
• These principles facilitate biomarker discovery and validation, enhancing research reliability.